StreetInsider.com News Articles

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 02 Dec 2025 01:30:00 -0400

The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT” or “CARMAT SA”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure

On November 4, 2025, CARMAT had announced it had received a takeover bid within

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 02 Dec 2025 01:30:00 -0400

The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS

PARIS--(BUSINESS WIRE)-- Regulatory News:

Update on the ongoing receivership procedure

On November 4, 2025, CARMAT had announced it had received a takeover bid within

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 02 Dec 2025 01:30:00 -0400

The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS

PARIS--(BUSINESS WIRE)-- Regulatory News:

Update on the ongoing receivership procedure

On November 4, 2025, CARMAT had announced it had received a takeover bid within

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 02 Dec 2025 01:30:00 -0400

The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS

PARIS--(BUSINESS WIRE)-- Regulatory News:

Update on the ongoing receivership procedure

On November 4, 2025, CARMAT had announced it had received a takeover bid within

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 02 Dec 2025 01:30:00 -0400

The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS

PARIS--(BUSINESS WIRE)-- Regulatory News:

Update on the ongoing receivership procedure

On November 4, 2025, CARMAT had announced it had received a takeover bid within

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 02 Dec 2025 01:30:00 -0400

The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS

PARIS--(BUSINESS WIRE)-- Regulatory News:

Update on the ongoing receivership procedure

On November 4, 2025, CARMAT had announced it had received a takeover bid within

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 02 Dec 2025 01:30:00 -0400

The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS

PARIS--(BUSINESS WIRE)-- Regulatory News:

Update on the ongoing receivership procedure

On November 4, 2025, CARMAT had announced it had received a takeover bid within

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 02 Dec 2025 01:30:00 -0400

The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS

PARIS--(BUSINESS WIRE)-- Regulatory News:

Update on the ongoing receivership procedure

On November 4, 2025, CARMAT had announced it had received a takeover bid within

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 04 Nov 2025 11:30:00 -0400

A takeover bid within the context of a sales plan has been received by the judiciary administrator

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure

On October 15, 2025, CARMAT had announced a new call for public tenders (buyers or investors) initiated as part of the receivership opened on July 1, 2025. The deadline set for submitting

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 04 Nov 2025 11:30:00 -0400

A takeover bid within the context of a sales plan has been received by the judiciary administrator

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure

On October 15, 2025, CARMAT had announced a new call for public tenders (buyers or investors) initiated as part of the receivership opened on July 1, 2025. The deadline set for submitting

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 04 Nov 2025 11:30:00 -0400

A takeover bid within the context of a sales plan has been received by the judiciary administrator

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure

On October 15, 2025, CARMAT had announced a new call for public tenders (buyers or investors) initiated as part of the receivership opened on July 1, 2025. The deadline set for submitting

CARMAT Provides an Update on the Ongoing Receivership Procedure

Tue, 04 Nov 2025 11:30:00 -0400

A takeover bid within the context of a sales plan has been received by the judiciary administrator

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure

On October 15, 2025, CARMAT had announced a new call for public tenders (buyers or investors) initiated as part of the receivership opened on July 1, 2025. The deadline set for submitting

CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)

Wed, 29 Oct 2025 02:30:00 -0400

PARIS--(BUSINESS WIRE)--

Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces postponing the publication of its 2025 interim financial report (six months ended June 30, 2025).

Reminder on the ongoing receivership procedure

CARMAT has been under receivership procedure since July 1, 2025.

During a hearing on September 30, 2025, the Versailles Economic Court1 (the "Court") had acknowledged that the only take-over-bid within the context of a sales plan which had been received, had

CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)

Wed, 29 Oct 2025 02:30:00 -0400

PARIS--(BUSINESS WIRE)--

Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces postponing the publication of its 2025 interim financial report (six months ended June 30, 2025).

Reminder on the ongoing receivership procedure

CARMAT has been under receivership procedure since July 1, 2025.

During a hearing on September 30, 2025, the Versailles Economic Court1 (the "Court") had acknowledged that the only take-over-bid within the context of a sales plan which had been received, had

CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)

Wed, 29 Oct 2025 02:30:00 -0400

PARIS--(BUSINESS WIRE)--

Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces postponing the publication of its 2025 interim financial report (six months ended June 30, 2025).

Reminder on the ongoing receivership procedure

CARMAT has been under receivership procedure since July 1, 2025.

During a hearing on September 30, 2025, the Versailles Economic Court1 (the "Court") had acknowledged that the only take-over-bid within the context of a sales plan which had been received, had

CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)

Wed, 29 Oct 2025 02:30:00 -0400

PARIS--(BUSINESS WIRE)--

Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces postponing the publication of its 2025 interim financial report (six months ended June 30, 2025).

Reminder on the ongoing receivership procedure

CARMAT has been under receivership procedure since July 1, 2025.

During a hearing on September 30, 2025, the Versailles Economic Court1 (the "Court") had acknowledged that the only take-over-bid within the context of a sales plan which had been received, had

CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)

Wed, 29 Oct 2025 02:30:00 -0400

PARIS--(BUSINESS WIRE)--

Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces postponing the publication of its 2025 interim financial report (six months ended June 30, 2025).

Reminder on the ongoing receivership procedure

CARMAT has been under receivership procedure since July 1, 2025.

During a hearing on September 30, 2025, the Versailles Economic Court1 (the "Court") had acknowledged that the only take-over-bid within the context of a sales plan which had been received, had

CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)

Wed, 29 Oct 2025 02:30:00 -0400

PARIS--(BUSINESS WIRE)--

Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces postponing the publication of its 2025 interim financial report (six months ended June 30, 2025).

Reminder on the ongoing receivership procedure

CARMAT has been under receivership procedure since July 1, 2025.

During a hearing on September 30, 2025, the Versailles Economic Court1 (the "Court") had acknowledged that the only take-over-bid within the context of a sales plan which had been received, had

CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)

Wed, 29 Oct 2025 02:30:00 -0400

PARIS--(BUSINESS WIRE)--

Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces postponing the publication of its 2025 interim financial report (six months ended June 30, 2025).

Reminder on the ongoing receivership procedure

CARMAT has been under receivership procedure since July 1, 2025.

During a hearing on September 30, 2025, the Versailles Economic Court1 (the "Court") had acknowledged that the only take-over-bid within the context of a sales plan which had been received, had

CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)

Wed, 29 Oct 2025 02:30:00 -0400

PARIS--(BUSINESS WIRE)--

Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces postponing the publication of its 2025 interim financial report (six months ended June 30, 2025).

Reminder on the ongoing receivership procedure

CARMAT has been under receivership procedure since July 1, 2025.

During a hearing on September 30, 2025, the Versailles Economic Court1 (the "Court") had acknowledged that the only take-over-bid within the context of a sales plan which had been received, had

CARMAT Provides an Update on the Ongoing Receivership Procedure

Wed, 15 Oct 2025 01:30:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure

Following a call for public tenders (buyers or investors) initiated as part of the receivership opened on July 1, 2025, by the Versailles Economic Court1 (the "Court"), the judiciary administrator had received, on July 31, 2025, one takeover bid within the context of a sales plan (the “Bid”)2, submitted

CARMAT Provides an Update on the Ongoing Receivership Procedure

Wed, 15 Oct 2025 01:30:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure

CARMAT Provides an Update on the Ongoing Receivership Procedure

Wed, 15 Oct 2025 01:30:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure

CARMAT Provides an Update on the Ongoing Receivership Procedure

Wed, 15 Oct 2025 01:30:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure

CARMAT Provides an Update on the Ongoing Receivership Procedure

Wed, 15 Oct 2025 01:30:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on the ongoing receivership procedure.

Update on the ongoing receivership procedure